157 related articles for article (PubMed ID: 14621966)
1. Preparation of biodegradable microspheres and matrix devices containing naltrexone.
Dinarvand R; Moghadam SH; Mohammadyari-Fard L; Atyabi F
AAPS PharmSciTech; 2003; 4(3):E34. PubMed ID: 14621966
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo release of naltrexone from biodegradable depot systems.
Liu Y; Sunderland VB; O'Neil AG
Drug Dev Ind Pharm; 2006 Jan; 32(1):85-94. PubMed ID: 16455607
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of tri-block poly(lactide)-poly(ethylene glycol)-poly(lactide) nanogels for controlled release of naltrexone.
Asadi H; Rostamizadeh K; Salari D; Hamidi M
Int J Pharm; 2011 Sep; 416(1):356-64. PubMed ID: 21729744
[TBL] [Abstract][Full Text] [Related]
4. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
Dorati R; Genta I; Colzani B; Tripodo G; Conti B
Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
[TBL] [Abstract][Full Text] [Related]
5. Optimizing Process Parameters for Controlled Drug Delivery: A Quality by Design (QbD) Approach in Naltrexone Microspheres.
Reddy PL; Shanmugasundaram S
AAPS PharmSciTech; 2024 May; 25(5):105. PubMed ID: 38724807
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable bromocryptine mesylate microspheres prepared by a solvent evaporation technique. I: Evaluation of formulation variables on microspheres characteristics for brain delivery.
Arica B; Kaş HS; Orman MN; Hincal AA
J Microencapsul; 2002; 19(4):473-84. PubMed ID: 12396384
[TBL] [Abstract][Full Text] [Related]
7. Effect of surfactant HLB and different formulation variables on the properties of poly-D,L-lactide microspheres of naltrexone prepared by double emulsion technique.
Dinarvand R; Moghadam SH; Sheikhi A; Atyabi F
J Microencapsul; 2005 Mar; 22(2):139-51. PubMed ID: 16019900
[TBL] [Abstract][Full Text] [Related]
8. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
Uchida T; Yagi A; Oda Y; Goto S
J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
Pagar KP; Vavia PR
Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
[TBL] [Abstract][Full Text] [Related]
10. Microencapsulation of gentamicin in biodegradable PLA and/or PLA/PEG copolymer.
Huang YY; Chung TW
J Microencapsul; 2001; 18(4):457-65. PubMed ID: 11428675
[TBL] [Abstract][Full Text] [Related]
11. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.
Yang YY; Chung TS; Ng NP
Biomaterials; 2001 Feb; 22(3):231-41. PubMed ID: 11197498
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.
Felder ChB; Blanco-Príeto MJ; Heizmann J; Merkle HP; Gander B
J Microencapsul; 2003; 20(5):553-67. PubMed ID: 12909541
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable progesterone microsphere delivery system for osteoporosis therapy.
Yang Q; Owusu-Ababio G
Drug Dev Ind Pharm; 2000 Jan; 26(1):61-70. PubMed ID: 10677811
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide.
Haznedar S; Dortunç B
Int J Pharm; 2004 Jan; 269(1):131-40. PubMed ID: 14698584
[TBL] [Abstract][Full Text] [Related]
15. In vitro degradation study of polyester microspheres by a new HPLC method for monomer release determination.
Giunchedi P; Conti B; Scalia S; Conte U
J Control Release; 1998 Dec; 56(1-3):53-62. PubMed ID: 9801429
[TBL] [Abstract][Full Text] [Related]
16. Modulation of rifampicin release from spray-dried microspheres using combinations of poly-(DL-lactide).
Bain DF; Munday DL; Smith A
J Microencapsul; 1999; 16(3):369-85. PubMed ID: 10340221
[TBL] [Abstract][Full Text] [Related]
17. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
Ma G
J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods.
Herrmann J; Bodmeier R
Eur J Pharm Biopharm; 1998 Jan; 45(1):75-82. PubMed ID: 9689538
[TBL] [Abstract][Full Text] [Related]
19. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
20. The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs.
Bile J; Bolzinger MA; Vigne C; Boyron O; Valour JP; Fessi H; Chevalier Y
Int J Pharm; 2015 Oct; 494(1):152-66. PubMed ID: 26235922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
